This Automated And Rapid Microbiological Tests Market research report contains a complete background analysis of the industry, which includes an assessment of the parental market. All the statistical and numerical that have been forecasted in this report is represented with the help of graphs, charts, or tables which makes this report more user-friendly. This Automated And Rapid Microbiological Tests Market report contains a thorough description, competitive scenario, wide product portfolio of key vendors, and business strategy adopted by competitors along with their SWOT analysis and porter’s five force analysis. Whether it is about renewing a business plan, preparing a presentation for a key client, or giving recommendations to an executive, this Automated And Rapid Microbiological Tests Market report will surely help you to a degree.
Read Detailed Index of full Research Study @ https://www.absolutemarketsinsights.com/reports/Automated-And-Rapid-Microbiological-Tests-Market-633
In terms of revenue, global automated and rapid microbiological tests market is anticipated to grow at a CAGR of 22.12% over the forecast period. Merck KGaA, Charles River Laboratories, MicroBio Corporation, BIOMÉRIEUX SA, Hygiena, LLC, Pall Corporation, Creative Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., HiMedia Laboratories, The MERLIN society for microbiological diagnostics GmbH and Rapid Test Methods Ltd. amongst others.
Global Automated and Rapid Microbiological Tests Market:
- Incubating/Reading Instrument and Proprietary Vials
- Support and Services
Growth Based Technology
- Colorimetric growth detection
- Autofluorescence detection
- Molecular biology-based microbial detection systems
- Endotoxin testing
- Rapid air monitoring
- Image Analysis for Enumeration of Microorganisms
By Organization Size
- Large Enterprises
- Small and Medium Enterprises
- Pharmaceutical manufacturing facilities
- Rapid detection of airborne contamination in clean areas
- Pharmaceutical microbiology laboratories
- Food manufacturing and microbiology sectors
- Water microbiology sectors
- Raw material testing
- In-process testing
- Bioburden assessment
- Home, and beauty product manufacturing facilities
- North America
- Rest of North America
- The UK
- Nordic Countries
- Benelux Union
- The Netherlands
- Rest of Europe
- Asia Pacific
- New Zealand
- South Korea
- Southeast Asia
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Latin America
- Rest of Latin America
The growing investments across pharmaceutical firms for development of novel drugs to deliver enhanced care against illnesses is driving the demand for automated and rapid microbiological test kits and services.
The routine microbiological testing carried out by the pharmaceutical manufacturing industry is higher than any other firms owing to the stringent regulatory compliance requirements. Performing microbiological tests based on traditional culture methods is a labour-intensive, time consuming method and involves a series of complex steps handled by humans which makes it prone to errors. The on-going investments in pharmaceutical firms to develop novel antibiotics and advanced therapy medicinal products (ATMPs) is creating demand for rapid microbiological testing capabilities. Rapid microbiological methods can quickly detect or identify microorganisms in a sample using biological, biochemical, molecular or chemical means. Use of automation technologies in microbiological testing can provide significant time and cost savings and release the skilled labour from repetitive manual tasks such as media preparation and specimen preparation (planting, inoculation and other activities). This reduction in human intervention reduces the potential human errors and provides more reliable and accurate results. The automated microbial testing technologies also increases the testing volume, and frees the resources of labs for other activities.
Pharmaceutical manufacturing companies developing ATMP medicines that are based on genes (Gene Therapy Medicinal Products), cells (Cell Therapy Medicinal Products) or tissues (Tissue Engineered Products). These medicines are finding applications in treatment of diseases such as cancer, neurodegenerative and cardiovascular diseases. These products have a very short shelf-life and are produced in small quantities as per requirement of individual patient which creates demand for rapid microbiological sterility testing for detecting bacterial and fungal contamination before administering the ATMP medicines to patients. The Microsart ATMP Sterile Release kit of Sartorius AG, an automated and rapid microbiological test products manufacturer, provides sterility testing results of ATMP drugs within 3 hours. Similarly, the antibody and antigen tests are performed through rapid microbiological testing methods in the development of antibiotic drugs. Thus, the growing development of novel drugs is fuelling the demand across global automated and rapid microbiological tests market.
However, the high cost associated with the massive computing power required to automate the microbiological testing and complexity in selecting the optimal method is hindering the growth of global automated and rapid microbiological tests market.
The recent outbreak of COVID-19 pandemic has fuelled the activities for developing vaccines to control the spread of this infectious disease. This race amongst researchers around the globe to develop an effective vaccine has inflated the demand for automated and rapid microbiological testing to ensure that the vaccine is safe and to get accepted by regulatory authorities. The microbiological laboratories across the globe are witnessing high demand for performing rapid immunoassay tests to detect SARS-CoV-2 antigens or antibodies. Also, ever vaccine and injection in development that is administered to patients are required to go through sterility testing. The Celsis rapid sterility testing platform of Charles River Laboratories can help companies to reduce the sterility testing of vaccine from 14 days to 6 days and that of in-process testing from 4 to 7 days to 24 hours. Thus, the requirement to rapidly perform laboratory testing of different aspects for developing COVID-19 vaccine is anticipated to fuel the global automated and rapid microbiological tests market in coming years.
Key Questions Answered with this Study
1) What makes Automated And Rapid Microbiological Tests Market feasible for long term investment?
2) Know value chain areas where players can create value?
3) Teritorry that may see steep rise in CAGR & Y-O-Y growth?
4) What geographic region would have better demand for product/services?
5) What opportunity emerging territory would offer to established and new entrants in Automated And Rapid Microbiological Tests market?
6) Risk side analysis connected with service providers?
7) How influencing factors driving the demand of Automated And Rapid Microbiological Tests in next few years?
8) What is the impact analysis of various factors in the Automated And Rapid Microbiological Tests market growth?
9) What strategies of big players help them acquire share in mature market?
10) How Technology and Customer-Centric Innovation is bringing big Change in Automated And Rapid Microbiological Tests Market?
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-7400-24-24-24, US +1-510-420-1213